Literature DB >> 31313978

Comparison of eVisit Management of Urinary Symptoms and Urinary Tract Infections with Standard Care.

Martha A Murray1,2, Kristine S Penza1,2, Jane F Myers2, Joseph W Furst2, Jennifer L Pecina2.   

Abstract

Background: Urinary symptoms and urinary tract infections (UTIs) are common complaints for which women seek health care. Evolving modalities of care delivery have shifted management of these complaints from in-person face-to-face (F2F) visits, to nurse phone protocol management, and recently to online assessment via eVisit. While research has vetted the use of nurse phone protocol management, eVisit management outcomes have not been thoroughly studied. Purpose: To compare antibiotic prescribing, follow-up rates, and clinical outcomes between F2F visits at a retail clinic, nurse phone protocol encounters, and eVisits for the assessment and management of urinary symptoms and UTIs.
Methods: A retrospective chart review of primary care empaneled patients at Mayo Clinic Rochester was conducted of females, 18 to 65 years old, who sought care for urinary symptoms via phone, eVisit, or F2F visit from August 1, 2016, through May 1, 2017. A total of 450 encounters, 150 from each of the 3 encounter types, were manually reviewed and compared for antibiotic prescribing rates, clinical outcomes, and 30-day follow-up rates.
Results: Antibiotic prescribing rates for all three encounter types were similar. Referral for follow-up at initial encounter was more likely to be recommended from phone and eVisit encounters than F2F. No significant differences in follow-up rates or clinical outcomes were noted between the three encounter types. Conclusions: eVisits for urinary symptoms and UTI offer patients a convenient option for care without an increased use of antimicrobials, follow-up, or adverse clinical outcomes when compared with F2F visits or nurse-administered phone protocols.

Entities:  

Keywords:  eVisits; electronic visits; primary care; telemedicine; urinary tract infection

Mesh:

Year:  2019        PMID: 31313978     DOI: 10.1089/tmj.2019.0044

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  6 in total

1.  Impact of Asynchronous Electronic Communication-Based Visits on Clinical Outcomes and Health Care Delivery: Systematic Review.

Authors:  Oliver T Nguyen; Amir Alishahi Tabriz; Jinhai Huo; Karim Hanna; Christopher M Shea; Kea Turner
Journal:  J Med Internet Res       Date:  2021-05-05       Impact factor: 5.428

2.  Impact of Remote Consultations on Antibiotic Prescribing in Primary Health Care: Systematic Review.

Authors:  Seung Min Han; Geva Greenfield; Azeem Majeed; Benedict Hayhoe
Journal:  J Med Internet Res       Date:  2020-11-09       Impact factor: 5.428

3.  Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study.

Authors:  Artin Entezarjou; Susanna Calling; Tapomita Bhattacharyya; Veronica Milos Nymberg; Lina Vigren; Ashkan Labaf; Ulf Jakobsson; Patrik Midlöv
Journal:  JMIR Med Inform       Date:  2021-03-15

4.  Health care utilization following "digi-physical" assessment compared to physical assessment for infectious symptoms in primary care.

Authors:  Artin Entezarjou; Maria Sjöbeck; Patrik Midlöv; Veronica Milos Nymberg; Lina Vigren; Ashkan Labaf; Ulf Jakobsson; Susanna Calling
Journal:  BMC Prim Care       Date:  2022-01-12

5.  Antibiotic prescribing for acute infections in synchronous telehealth consultations: a systematic review and meta-analysis.

Authors:  Mina Bakhit; Emma Baillie; Natalia Krzyzaniak; Mieke van Driel; Justin Clark; Paul Glasziou; Christopher Del Mar
Journal:  BJGP Open       Date:  2021-12-14

6.  Outpatient antibiotic prescribing for common infections via telemedicine versus face-to-face visits: Systematic literature review and meta-analysis.

Authors:  Hiroyuki Suzuki; Alexandre R Marra; Shinya Hasegawa; Daniel J Livorsi; Michihiko Goto; Eli N Perencevich; Michael E Ohl; Jennifer DeBerg; Marin L Schweizer
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.